Centessa Pharmaceuticals (CNTA)

14.57

0.06 (0.41%)

At close: Mar 28, 2025, 3:59 PM

13.62

-6.52%

Pre-market: Mar 31, 2025, 04:29 AM EDT

Centessa Pharmaceuticals Cash Flow Statement

Table Mode

Year	FY24	FY23	FY22	FY21	FY20	FY19
Net Income	-235.76M	-151.09M	-216.21M	-381.85M	-10.66M	-5.06M
Depreciation & Amortization	942K	810K	131K	33.99K	n/a	6K
Stock-Based Compensation	33.55M	29.39M	24.96M	14.85M	336K	236K
Other Working Capital	26.69M	-16.13M	-9.18M	1.34M	-440K	-1.86M
Other Non-Cash Items	34.46M	6.03M	-3.75M	257.85M	186K	-770
Deferred Income Tax	2.65M	-26.63M	-2.86M	-6.8M	n/a	770.00
Change in Working Capital	22.1M	-18.86M	-2.83M	-5.38M	-489K	-1.01M
Operating Cash Flow	-142.06M	-160.34M	-200.55M	-136.14M	-10.63M	-5.83M
Capital Expenditures	-34K	-169K	-1.14M	-185.98K	n/a	n/a
Acquisitions	n/a	n/a	n/a	63.43M	n/a	n/a
Purchase of Investments	31.3M	-264.91M	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	138.07M	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	206K	-1	n/a	n/a
Investing Cash Flow	31.27M	-127M	-931K	63.25M	n/a	n/a
Debt Repayment	-762K	n/a	n/a	73.93M	1.36M	3.83M
Common Stock Repurchased	n/a	n/a	n/a	-12K	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	5.91M	310K	457K	586.14M	1K	5.17M
Financial Cash Flow	364.75M	21.12M	457K	660.07M	1.36M	9.01M
Net Cash Flow	255.19M	-265.61M	-201.44M	590.08M	-9.34M	3.7M
Free Cash Flow	-142.09M	-160.51M	-201.68M	-136.33M	-10.63M	-5.83M